4,911 reports of this reaction
7.8% of all NICOTINE POLACRILEX reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for NICOTINE POLACRILEX, manufactured by Haleon US Holdings LLC. There are 4,911 FDA adverse event reports linking NICOTINE POLACRILEX to DRUG INEFFECTIVE. This represents approximately 7.8% of all 62,946 adverse event reports for this drug.
NICOTINE POLACRILEX has an overall safety score of 78 out of 100. Patients taking NICOTINE POLACRILEX who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among NICOTINE POLACRILEX users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for NICOTINE POLACRILEX:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 4,911 FDA reports for NICOTINE POLACRILEX. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 7.8% of all adverse event reports for NICOTINE POLACRILEX, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking NICOTINE POLACRILEX, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.